OMEROS CORP Increase (Decrease) in Deferred Revenue
OMEROS CORP (OMER) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2016-03-15
- OMEROS CORP increase (decrease) in deferred revenue for the quarter ending 2014-12-31 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for the quarter ending 2014-09-30 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for the quarter ending 2014-06-30 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for the quarter ending 2014-03-31 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for fiscal 2015 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for fiscal 2014 was $0.00.
- OMEROS CORP increase (decrease) in deferred revenue for fiscal 2013 was -$970.00K.
- OMEROS CORP increase (decrease) in deferred revenue for fiscal 2012 was -$4.72M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 204 month | Increase (Decrease) in Deferred Revenue 207 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | -$970.00K 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | -$970.00K 10-Q · filed 2014-11-10 | -$2.41M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$970.00K 10-Q · filed 2014-08-11 | -$2.41M derived: sum of 3 quarters · filed 2015-03-16 | -$3.74M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | -$970.00K 10-Q · filed 2014-05-12 | -$2.41M derived: sum of 2 quarters · filed 2015-03-16 | -$3.74M derived: sum of 3 quarters · filed 2015-03-16 | -$4.93M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$2.77M derived: sum of 2 quarters · filed 2015-03-16 | -$3.96M derived: sum of 3 quarters · filed 2015-03-16 | -$4.72M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$2.52M derived: sum of 2 quarters · filed 2013-11-07 | -$3.28M 10-Q · filed 2013-11-07 | -$3.81M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$1.95M 10-Q · filed 2013-08-09 | -$2.48M derived: sum of 3 quarters · filed 2014-03-13 | -$2.98M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | -$753.00K 10-Q · filed 2013-05-09 | -$1.29M derived: sum of 2 quarters · filed 2014-03-13 | -$1.78M derived: sum of 3 quarters · filed 2014-03-13 | -$2.26M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | -$534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$1.03M derived: sum of 2 quarters · filed 2014-03-13 | -$1.51M derived: sum of 3 quarters · filed 2014-03-13 | -$2.23M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | -$492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$972.00K derived: sum of 2 quarters · filed 2012-11-09 | -$1.69M 10-Q · filed 2012-11-09 | $10.10M derived: sum of 4 quarters · filed 2013-03-18 | $9.16M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$480.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$1.20M 10-Q · filed 2012-08-07 | $10.59M derived: sum of 3 quarters · filed 2013-03-18 | $10.47M derived: sum of 4 quarters · filed 2013-03-18 | $9.65M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | -$722.00K 10-Q · filed 2012-05-10 | $11.07M derived: sum of 2 quarters · filed 2013-03-18 | $10.95M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $11.79M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $11.68M derived: sum of 2 quarters · filed 2013-03-18 | $11.45M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$340.00K 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | -$224.00K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $470.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |